Owner Vertex Pharmaceuticals Incorporated

Inventors Charrier, Jean-Damien; Bebbington, David; Li, Pan; Knegtel, Ronald; Golec, Julian M.C.; Davies, Robert

Agent Cullen & Co

Pub. Number AU-B-2006201265

Parent 2001296871

Filing date 21 March 2006

Wipo publication date 27 April 2006

Acceptance publication date 4 September 2008

C07D 403/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/53 (2006.01) - having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine

A61P 35/00 (2006.01) Antineoplastic agents

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 403/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 405/14 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 521/00 (2006.01) Heterocyclic compounds containing unspecified hetero rings